Streetbeat News

Products Services

SURG

SurgePays has announced the launch of ClearLine's POS marketing solution, which is integrated with Clover and PAX devices. This new solution will debut at the RSPA RetailNOW Conference in Las Vegas.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:31 pm

CSIQ

Canadian Solar's subsidiary, Recurrent Energy, has secured a €50 million loan from the European Investment Bank to develop a solar energy portfolio in Italy. This move strengthens Recurrent Energy's position in Italy's clean energy market and supports Europe's renewable energy goals.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:30 pm

META

MSFT

Meta Platforms CEO Mark Zuckerberg praised Sam Altman's leadership at OpenAI but highlighted the irony of a company named OpenAI leading in closed AI models. Zuckerberg's comments reflect ongoing industry debates about open-source versus closed-source AI development.

Portfolio Pulse from Ananya Gairola

July 24, 2024 | 12:30 pm

NVGS

Navigator Gas, Bumi Armada, and Bluestreak CO2 have signed a memorandum of understanding with Uniper to study the export of CO2 emissions, aiming to help the UK government decarbonize the power sector by 2030.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:28 pm

CRWD

MSFT

CrowdStrike Holdings Inc. (NASDAQ:CRWD) disclosed that a flawed security update caused a global outage affecting 8.5 million Windows computers. The issue originated from the Falcon platform's Rapid Response Content. CrowdStrike has reverted the defective update and is working on enhancing its testing processes. Microsoft Corp (NASDAQ:MSFT) was also impacted, with its Windows users experiencing the outage. Analysts predict potential costs over $1 billion and possible lawsuits.

Portfolio Pulse from Benzinga Neuro

July 24, 2024 | 12:28 pm

PFE

SGMO

Sangamo Therapeutics announced that Pfizer's Phase 3 trial of Giroctocogene Fitelparvovec met its primary and key secondary objectives. Sangamo is eligible for up to $220 million in milestone payments and 14%-20% royalties if the therapy is approved and commercialized.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:28 pm

NVS

Dren Bio has entered into a strategic collaboration with Novartis to develop novel targeted myeloid engagers for cancer. Dren Bio will receive $150 million upfront and is eligible for milestone payments and tiered royalties.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:25 pm

DXR

Daxor Corporation (NASDAQ:DXR) has been awarded a $550K contract extension from the U.S. Defense Health Agency to enhance its blood volume analyzer with hematocrit measurement capabilities, eliminating the need for third-party devices.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:21 pm

SMXT

SolarMax Technology, Inc. (Nasdaq: SMXT) plans to offer engineering, procurement, and construction (EPC) services for large-scale solar systems in the U.S. The company has signed a non-binding MOU for its first major commercial solar installation project in Las Vegas.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:20 pm

MGRX

Mangoceuticals has initiated efficacy studies on its patented respiratory illness prevention technology in collaboration with Vipragen Biosciences and IntraMont Technologies. The studies are pre-funded and expected to be completed by early Q3 2024.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:19 pm